首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   30276篇
  免费   2160篇
  国内免费   292篇
耳鼻咽喉   560篇
儿科学   468篇
妇产科学   407篇
基础医学   4853篇
口腔科学   852篇
临床医学   2723篇
内科学   5961篇
皮肤病学   1060篇
神经病学   2392篇
特种医学   1711篇
外科学   3884篇
综合类   153篇
现状与发展   3篇
一般理论   9篇
预防医学   1219篇
眼科学   594篇
药学   2875篇
中国医学   427篇
肿瘤学   2577篇
  2024年   29篇
  2023年   229篇
  2022年   772篇
  2021年   1162篇
  2020年   647篇
  2019年   889篇
  2018年   1048篇
  2017年   821篇
  2016年   1176篇
  2015年   1562篇
  2014年   1669篇
  2013年   2004篇
  2012年   2909篇
  2011年   2735篇
  2010年   1618篇
  2009年   1264篇
  2008年   1825篇
  2007年   1611篇
  2006年   1358篇
  2005年   1289篇
  2004年   1043篇
  2003年   932篇
  2002年   765篇
  2001年   414篇
  2000年   396篇
  1999年   325篇
  1998年   150篇
  1997年   135篇
  1996年   94篇
  1995年   77篇
  1994年   74篇
  1993年   67篇
  1992年   121篇
  1991年   134篇
  1990年   113篇
  1989年   102篇
  1988年   95篇
  1987年   78篇
  1986年   83篇
  1985年   64篇
  1984年   42篇
  1983年   39篇
  1979年   53篇
  1978年   39篇
  1975年   52篇
  1974年   29篇
  1972年   39篇
  1971年   49篇
  1970年   34篇
  1968年   31篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
3.
4.
Introduction: Immune checkpoint inhibitors (ICI) are now a standard of care in the treatment of many cancers leading to durable responses in patients with metastatic disease. These agents are generally well tolerated but may lead to the occurrence of immune-related adverse events (irAEs). As any organ may be affected, clinicians should be aware of the broad range of clinical manifestations and symptoms and keep in mind that toxicities may occur late, at any point along a patient’s treatment course. Although the most common irAEs are rarely severe, some of them may be associated with great morbidity and even become life-threatening. The rate of occurrence, type and severity of irAEs may vary with the type of ICI; thus, grade 3 and 4 irAEs are reported in more than 55% of patients treated with the combination of ipilimumab 3 mg/kg and nivolumab 1 mg/kg.

Area covered: This review presents the management of irAEs resulting from checkpoint blockade, with a focus on rare irAEs.

Expert commentary: With the development of immuno-oncology and the expanding role of ICI, physicians have learnt to diagnose and treat most of the irAEs that can occur. This review provides an overview of current guidelines, previously published studies and our multidisciplinary team based practices.  相似文献   

5.
6.
ABSTRACT

Purpose

Work-related eye injuries have been reported with a variety of epidemiologic and clinical characteristics. We aimed to identify epidemiologic characteristics of work-related eye injuries and risk factors associated with severe injury in a large metropolitan city.  相似文献   
7.
Scrub typhus usually presents as acute undifferentiated fever. This cross-sectional study included adult patients presenting with acute undifferentiated fever defined as any febrile illness for ≤ 14 days without evidence of localized infection. Scrub typhus cases were defined by an antibody titer of a ≥ fourfold increase in paired sera, a ≥ 1:160 in a single serum using indirect immunofluorescence assay, or a positive result of the immunochromatographic test. Multiple regression analysis identified predictors associated with scrub typhus to develop a prediction rule. Of 250 cases with known etiology of acute undifferentiated fever, influenza (28.0%), hepatitis A (25.2%), and scrub typhus (16.4%) were major causes. A prediction rule for identifying suspected cases of scrub typhus consisted of age ≥ 65 years (two points), recent fieldwork/outdoor activities (one point), onset of illness during an outbreak period (two points), myalgia (one point), and eschar (two points). The c statistic was 0.977 (95% confidence interval = 0.960–0.994). At a cutoff value ≥ 4, the sensitivity and specificity were 92.7% (79.0–98.1%) and 90.9% (86.0–94.3%), respectively. Scrub typhus, the third leading cause of acute undifferentiated fever in our region, can be identified early using the prediction rule.  相似文献   
8.
9.
10.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号